Table 2.

Essential oils’ (EOs’) anti-HSV-1 (IC₅₀), cytotoxicity (CC₅₀) and selectivity index (SI) of the tested EOs.

# a	EO Id b	IC50 (mg/mL)	CC50 (mg/mL)	SI	# a	EOs b	IC50 (mg/mL)	CC50 (mg/mL)	SI
1	FA2	0.14	1.45	9.70	20	CS6	0.21	2.66	12.48
2	FA6	0.16	1.82	11.31	21	CO1	0.21	2.50	11.89
3	FS1	0.19	1.01	5.17	22	CO2	0.33	>3.00	>9.0
4	FS2	0.19	0.31	1.61	23	CO6	0.17	2.22	12.08
5	FS6	0.19	1.51	7.78	24	CJM2	0.33	2.50	7.60
6	FO1	0.72	1.50	2.07	25	CJM5	0.14	>3.00	>22.2
7	FO3	0.65	1.02	1.58	26	CAM1	0.20	2.65	13.11
8	FO6	0.54	1.69	3.14	27	CAM3	0.15	2.99	19.50
9	FO24	0.58	0.36	0.61	28	CAM5	0.44	1.10	2.50
10	FOM3	0.18	1.7	9.63	29	CSM1	0.17	2.00	11.5
11	CJ1	0.27	2.15	7.87	30	CSM3	0.24	2.12	8.97
12	CJ2	0.14	>3.00	>22.2	31	CSM5	0.12	1.93	15.77
13	CA1	0.16	2.84	17.54	32	COM1	0.28	2.76	9.78
14	CA2	0.15	>3.00	>19.8	33	COM3	0.31	1.99	6.36
15	CA3	0.18	2.50	14.26	34	COM5	0.36	2.46	6.74
16	CA6	0.14	1.14	7.99	35	R6	0.43	0.41	0.94
17	CS1	0.14	2.50	17.82	36	R24	0.18	0.36	1.99
18	CS2	0.21	2.90	14.04	37	RM4	0.30	0.90	3.05
19	CS3	0.23	2.68	11.61	38	RM6	0.20	0.33	1.65

^a # EO number. ^b EO’s Id refers to that reported in reference [10] published by the same authors of this reports. SI = (CC₅₀/IC₅₀).